<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Asian J Sports Med</journal-id><journal-id journal-id-type="iso-abbrev">Asian J Sports Med</journal-id><journal-id journal-id-type="publisher-id">ASJSM</journal-id><journal-title-group><journal-title>Asian Journal of Sports Medicine</journal-title></journal-title-group><issn pub-type="ppub">2008-000X</issn><issn pub-type="epub">2008-7209</issn><publisher><publisher-name>Tehran University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24427480</article-id><article-id pub-id-type="pmc">3880665</article-id><article-id pub-id-type="publisher-id">ASJSM-4-208</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Changes of Serum Retinol Binding Protein 4 Levels Following 8 Weeks Moderate Aerobic Exercise</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ahmadi</surname><given-names>Narges</given-names></name><xref ref-type="aff" rid="AF0001">1</xref><xref ref-type="author-notes" rid="fn1">A</xref><xref ref-type="author-notes" rid="fn2">B</xref><xref ref-type="author-notes" rid="fn7">G</xref></contrib><contrib contrib-type="author"><name><surname>Moghadasi</surname><given-names>Mehrzad</given-names></name><degrees>PhD</degrees><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="aff" rid="AF0002">2</xref><xref ref-type="author-notes" rid="fn1">A</xref><xref ref-type="author-notes" rid="fn3">C</xref><xref ref-type="author-notes" rid="fn4">D</xref><xref ref-type="author-notes" rid="fn7">G</xref></contrib><contrib contrib-type="author"><name><surname>Nuri</surname><given-names>Reza</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0003">3</xref><xref ref-type="author-notes" rid="fn1">A</xref><xref ref-type="author-notes" rid="fn4">D</xref><xref ref-type="author-notes" rid="fn7">G</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Department of Exercise physiology, Fars Science &amp; Research branch, Islamic Azad University, Iran</aff><aff id="AF0002"><label>2</label>Department of Exercise physiology, Shiraz branch, Islamic Azad University, Shiraz, Iran</aff><aff id="AF0003"><label>3</label>Department of Physical Education and Sport Sciences, International Kish Campus, Iran</aff><author-notes><title>Authors’ Contribution</title><fn id="fn1"><label>A</label><p>Concept / Design</p></fn><fn id="fn2"><label>B</label><p>Acquisition of Data</p></fn><fn id="fn3"><label>C</label><p>Data Analysis / Interpretation</p></fn><fn id="fn4"><label>D</label><p>Manuscript Preparation</p></fn><fn id="fn5"><label>E</label><p>Critical Revision of the Manuscript</p></fn><fn id="fn6"><label>F</label><p>Funds Collection</p></fn><fn id="fn7"><label>G</label><p>Approval of the Article</p></fn><corresp id="cor1"><label>*</label><bold>Address:</bold> Department of Exercise physiology, Shiraz branch, Islamic Azad University, Shiraz, Iran. <email xlink:href="moghadasi39@yahoo.com">moghadasi39@yahoo.com</email></corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>5</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2013</year></pub-date><volume>4</volume><issue>3</issue><fpage>208</fpage><lpage>212</lpage><history><date date-type="received"><day>25</day><month>11</month><year>2012</year></date><date date-type="accepted"><day>05</day><month>5</month><year>2013</year></date></history><permissions><copyright-statement>© 2013 Sports Medicine Research Center, Tehran University of Medical Sciences</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="4309" xml_f="4316" txt_i="11" txt_f="18">Purpose</offsets></title><p><offsets xml_i="4327" xml_f="4495" txt_i="19" txt_f="187">The purpose of this study was to examine the effects of 8 weeks moderate intensity aerobic exercise on serum retinol binding protein 4 (RBP4) levels in female athletes.</offsets></p></sec><sec id="st2"><title><offsets xml_i="4526" xml_f="4533" txt_i="189" txt_f="196">Methods</offsets></title><p><offsets xml_i="4544" xml_f="4826" txt_i="197" txt_f="479">Twenty female karate athletics were randomly assigned to one of the exercise group (n = 10) or control group (n = 10). The training group performed endurance training 3 days a week for 8 weeks at an intensity corresponding to 50-60% individual maximum oxygen consumption for 45 min.</offsets></p></sec><sec id="st3"><title><offsets xml_i="4857" xml_f="4864" txt_i="481" txt_f="488">Results</offsets></title><p><offsets xml_i="4875" xml_f="5300" txt_i="489" txt_f="911">Body mass and body mass index increased (P &lt; 0.05) after 8 weeks aerobic exercise compared to the control group. For waist to hip ratio (WHR), body fat percentage and maximal oxygen consumption there were no significant differences between the exercise group and the control group. There were virtually no changes in body fat percentage, fasting glucose, insulin, insulin resistance and RBP4 levels after 8 weeks training.</offsets></p></sec><sec id="st4"><title><offsets xml_i="5331" xml_f="5341" txt_i="913" txt_f="923">Conclusion</offsets></title><p><offsets xml_i="5352" xml_f="5441" txt_i="924" txt_f="1013">Serum RBP4 level was not affected by 8-week moderate aerobic exercise in female athletes.</offsets></p></sec></abstract><kwd-group><kwd>RBP4</kwd><kwd>Aerobic Exercise</kwd><kwd>Female Athletes</kwd><kwd>Insulin Resistance</kwd></kwd-group></article-meta></front><body><sec id="S0001"><title><offsets xml_i="5634" xml_f="5646" txt_i="1022" txt_f="1034">INTRODUCTION</offsets></title><p><offsets xml_i="5657" xml_f="5847" txt_i="1035" txt_f="1225">Retinol binding protein 4 (RBP4), another member of the lipocalin family, has recently been added to the list of adipokines that may link obesity with insulin resistance and type 2 diabetes </offsets><sup><offsets xml_i="5852" xml_f="5853" txt_i="1225" txt_f="1226">[</offsets><xref ref-type="bibr" rid="CIT0001"><offsets xml_i="5889" xml_f="5890" txt_i="1226" txt_f="1227">1</offsets></xref><offsets xml_i="5897" xml_f="5899" txt_i="1227" txt_f="1229">, </offsets><xref ref-type="bibr" rid="CIT0002"><offsets xml_i="5935" xml_f="5936" txt_i="1229" txt_f="1230">2</offsets></xref><offsets xml_i="5943" xml_f="5944" txt_i="1230" txt_f="1231">]</offsets></sup><offsets xml_i="5950" xml_f="6036" txt_i="1231" txt_f="1317">. RBP4 is a newly discovered fat derived adipokine that specifically binds to retinol </offsets><sup><offsets xml_i="6041" xml_f="6042" txt_i="1317" txt_f="1318">[</offsets><xref ref-type="bibr" rid="CIT0003"><offsets xml_i="6078" xml_f="6079" txt_i="1318" txt_f="1319">3</offsets></xref><offsets xml_i="6086" xml_f="6087" txt_i="1319" txt_f="1320">]</offsets></sup><offsets xml_i="6093" xml_f="6112" txt_i="1320" txt_f="1339"> and transthyretin </offsets><sup><offsets xml_i="6117" xml_f="6118" txt_i="1339" txt_f="1340">[</offsets><xref ref-type="bibr" rid="CIT0004"><offsets xml_i="6154" xml_f="6155" txt_i="1340" txt_f="1341">4</offsets></xref><offsets xml_i="6162" xml_f="6163" txt_i="1341" txt_f="1342">]</offsets></sup><offsets xml_i="6169" xml_f="6295" txt_i="1342" txt_f="1468">. In fact, elevated serum RBP4 levels were associated with the components of metabolic syndrome in insulin-resistant subjects </offsets><sup><offsets xml_i="6300" xml_f="6301" txt_i="1468" txt_f="1469">[</offsets><xref ref-type="bibr" rid="CIT0002"><offsets xml_i="6337" xml_f="6338" txt_i="1469" txt_f="1470">2</offsets></xref><offsets xml_i="6345" xml_f="6346" txt_i="1470" txt_f="1471">]</offsets></sup><offsets xml_i="6352" xml_f="6553" txt_i="1471" txt_f="1672">. Transgenic over expression of RBP4 or injection of recombinant RBP4 decreases insulin sensitivity in normal mice. In contrast, normalization of RBP4 levels in obese mice restores insulin sensitivity </offsets><sup><offsets xml_i="6558" xml_f="6559" txt_i="1672" txt_f="1673">[</offsets><xref ref-type="bibr" rid="CIT0001"><offsets xml_i="6595" xml_f="6596" txt_i="1673" txt_f="1674">1</offsets></xref><offsets xml_i="6603" xml_f="6604" txt_i="1674" txt_f="1675">]</offsets></sup><offsets xml_i="6610" xml_f="6634" txt_i="1675" txt_f="1699">. In addition, Seo et al</offsets><sup><offsets xml_i="6639" xml_f="6640" txt_i="1699" txt_f="1700">[</offsets><xref ref-type="bibr" rid="CIT0005"><offsets xml_i="6676" xml_f="6677" txt_i="1700" txt_f="1701">5</offsets></xref><offsets xml_i="6684" xml_f="6685" txt_i="1701" txt_f="1702">]</offsets></sup><offsets xml_i="6691" xml_f="6778" txt_i="1702" txt_f="1789"> demonstrated an association between RBP4 levels and non-alcoholic fatty liver disease.</offsets></p><p><offsets xml_i="6785" xml_f="7042" txt_i="1790" txt_f="2047">Exercise has been shown to have beneficial effects on obesity, type 2 diabetes, and the metabolic syndrome. Several studies exploring the effects of exercise on circulating RBP4 levels have resulted in inconsistent findings. Circulating RBP4 did not change </offsets><sup><offsets xml_i="7047" xml_f="7048" txt_i="2047" txt_f="2048">[</offsets><xref ref-type="bibr" rid="CIT0006"><offsets xml_i="7084" xml_f="7085" txt_i="2048" txt_f="2049">6</offsets></xref><offsets xml_i="7092" xml_f="7094" txt_i="2049" txt_f="2051">, </offsets><xref ref-type="bibr" rid="CIT0007"><offsets xml_i="7130" xml_f="7131" txt_i="2051" txt_f="2052">7</offsets></xref><offsets xml_i="7138" xml_f="7139" txt_i="2052" txt_f="2053">]</offsets></sup><offsets xml_i="7145" xml_f="7157" txt_i="2053" txt_f="2065">, decreased </offsets><sup><offsets xml_i="7162" xml_f="7163" txt_i="2065" txt_f="2066">[</offsets><xref ref-type="bibr" rid="CIT0008"><offsets xml_i="7199" xml_f="7200" txt_i="2066" txt_f="2067">8</offsets></xref><offsets xml_i="7207" xml_f="7208" txt_i="2067" txt_f="2068">–</offsets><xref ref-type="bibr" rid="CIT0010"><offsets xml_i="7244" xml_f="7246" txt_i="2068" txt_f="2070">10</offsets></xref><offsets xml_i="7253" xml_f="7254" txt_i="2070" txt_f="2071">]</offsets></sup><offsets xml_i="7260" xml_f="7274" txt_i="2071" txt_f="2085"> or increased </offsets><sup><offsets xml_i="7279" xml_f="7280" txt_i="2085" txt_f="2086">[</offsets><xref ref-type="bibr" rid="CIT0011"><offsets xml_i="7316" xml_f="7318" txt_i="2086" txt_f="2088">11</offsets></xref><offsets xml_i="7325" xml_f="7326" txt_i="2088" txt_f="2089">]</offsets></sup><offsets xml_i="7332" xml_f="7381" txt_i="2089" txt_f="2138"> in response to exercise. For example, Cho et al </offsets><sup><offsets xml_i="7386" xml_f="7387" txt_i="2138" txt_f="2139">[</offsets><xref ref-type="bibr" rid="CIT0006"><offsets xml_i="7423" xml_f="7424" txt_i="2139" txt_f="2140">6</offsets></xref><offsets xml_i="7431" xml_f="7432" txt_i="2140" txt_f="2141">]</offsets></sup><offsets xml_i="7438" xml_f="7574" txt_i="2141" txt_f="2277"> reported that there was no significant change in RBP4 levels in obese women after 12 weeks moderate exercise training, while Lim et al </offsets><sup><offsets xml_i="7579" xml_f="7580" txt_i="2277" txt_f="2278">[</offsets><xref ref-type="bibr" rid="CIT0008"><offsets xml_i="7616" xml_f="7617" txt_i="2278" txt_f="2279">8</offsets></xref><offsets xml_i="7624" xml_f="7625" txt_i="2279" txt_f="2280">]</offsets></sup><offsets xml_i="7631" xml_f="7713" txt_i="2280" txt_f="2362"> indicated that RBP4 levels decrease after 10 weeks exercise in middle-aged women.</offsets></p><p><offsets xml_i="7720" xml_f="8107" txt_i="2363" txt_f="2750">This study result showed that RBP4 levels were associated with obesity profiles and insulin resistance, thus we hypothesized that exercise training would reduce the adipose tissue, insulin resistance and RBP4 concentrations; therefore, we investigated the effects of 8 weeks of moderate aerobic exercise on body composition, insulin resistance and RBP4 concentrations in female athletes.</offsets></p></sec><sec id="S0002"><title><offsets xml_i="8140" xml_f="8160" txt_i="2752" txt_f="2772">METHODS AND SUBJECTS</offsets></title><sec id="S20003"><title><offsets xml_i="8192" xml_f="8200" txt_i="2773" txt_f="2781">Subjects</offsets></title><p><offsets xml_i="8211" xml_f="9010" txt_i="2782" txt_f="3577">Twenty female karate athletics (24.3 ± 4.8 years; mean ± SD) participated in this study. All the subjects were asked to complete a personal health and medical history questionnaire, which served as a screening tool. The subjects were given both verbal and written instructions outlining the experimental procedure, and written informed consent was obtained. Our participants were nonsmokers and none of them had any disease. All the subjects completed the 3-day diet recall forms and were instructed to maintain their normal physical activity and dietary habits throughout the study. The subjects were randomly assigned to one of either the exercise group (n = 10) or control group (n = 10). The study was approved by the Islamic Azad University, Fars Science &amp; Research branch Ethics Committee.</offsets></p></sec><sec id="S20004"><title><offsets xml_i="9044" xml_f="9061" txt_i="3579" txt_f="3596">Exercise training</offsets></title><p><offsets xml_i="9072" xml_f="9649" txt_i="3597" txt_f="4174">The 8 weeks exercise training program included 3 running sessions per week. The intensity of exercise was customized for each subject based on the relationship between heart rate and oxygen uptake measured at baseline. During the 8 weeks intervention, the subjects were trained for 45 min per session at a heart rate corresponding to 50-60% of the maximal oxygen uptake measured at baseline. Each participant wore a heart rate monitor (Beurer, PM70, Germany) to ensure accuracy of the exercise level. Subjects performed the exercise training besides their karate team training.</offsets></p></sec><sec id="S20005"><title><offsets xml_i="9683" xml_f="9695" txt_i="4176" txt_f="4188">Measurements</offsets></title><p><offsets xml_i="9706" xml_f="9707" txt_i="4189" txt_f="4190">
</offsets><italic><offsets xml_i="9715" xml_f="9764" txt_i="4190" txt_f="4239">Anthropometric and body composition measurements:</offsets></italic><offsets xml_i="9773" xml_f="9890" txt_i="4239" txt_f="4356"> Height and body mass were measured, and body mass index (BMI) was calculated by dividing body mass (kg) by height (m</offsets><sup><offsets xml_i="9895" xml_f="9896" txt_i="4356" txt_f="4357">2</offsets></sup><offsets xml_i="9902" xml_f="10199" txt_i="4357" txt_f="4654">). Waist circumference was determined by obtaining the minimum circumference (narrowest part of the torso, above the umbilicus) and the maximum hip circumference while standing with their heels together. The waist to hip ratio (WHR) was calculated by dividing waist (cm) by hip circumference (cm) </offsets><sup><offsets xml_i="10204" xml_f="10205" txt_i="4654" txt_f="4655">[</offsets><xref ref-type="bibr" rid="CIT0011"><offsets xml_i="10241" xml_f="10243" txt_i="4655" txt_f="4657">11</offsets></xref><offsets xml_i="10250" xml_f="10251" txt_i="4657" txt_f="4658">]</offsets></sup><offsets xml_i="10257" xml_f="10536" txt_i="4658" txt_f="4937">. Body fat percentage was assessed by skinfold thickness protocol. Skinfold thickness was measured sequentially, in triceps, suprailiac, and thigh by the same investigator using a skinfold caliper (Harpenden, HSK-BI, British Indicators, West Sussex, UK) and a standard technique </offsets><sup><offsets xml_i="10541" xml_f="10542" txt_i="4937" txt_f="4938">[</offsets><xref ref-type="bibr" rid="CIT0011"><offsets xml_i="10578" xml_f="10580" txt_i="4938" txt_f="4940">11</offsets></xref><offsets xml_i="10587" xml_f="10588" txt_i="4940" txt_f="4941">]</offsets></sup><offsets xml_i="10594" xml_f="10595" txt_i="4941" txt_f="4942">.</offsets></p><p><offsets xml_i="10602" xml_f="10603" txt_i="4943" txt_f="4944">
</offsets><italic><offsets xml_i="10611" xml_f="10628" txt_i="4944" txt_f="4961">Measurement of VO</offsets></italic><offsets xml_i="10637" xml_f="10638" txt_i="4961" txt_f="4962">
</offsets><sub><italic><offsets xml_i="10651" xml_f="10655" txt_i="4962" txt_f="4966">2max</offsets></italic></sub><offsets xml_i="10670" xml_f="10671" txt_i="4966" txt_f="4967">
</offsets><italic><offsets xml_i="10679" xml_f="10680" txt_i="4967" txt_f="4968">:</offsets></italic><offsets xml_i="10689" xml_f="10692" txt_i="4968" txt_f="4971"> VO</offsets><sub><offsets xml_i="10697" xml_f="10701" txt_i="4971" txt_f="4975">2max</offsets></sub><offsets xml_i="10707" xml_f="10912" txt_i="4975" txt_f="5180"> was determined by Rockport one-mile fitness walking test. In this test, an individual walked 1 mile as fast as possible on a track surface. Total time was recorded and HR was obtained in the final minute </offsets><sup><offsets xml_i="10917" xml_f="10918" txt_i="5180" txt_f="5181">[</offsets><xref ref-type="bibr" rid="CIT0011"><offsets xml_i="10954" xml_f="10956" txt_i="5181" txt_f="5183">11</offsets></xref><offsets xml_i="10963" xml_f="10964" txt_i="5183" txt_f="5184">]</offsets></sup><offsets xml_i="10970" xml_f="10974" txt_i="5184" txt_f="5188">. VO</offsets><sub><offsets xml_i="10979" xml_f="10983" txt_i="5188" txt_f="5192">2max</offsets></sub><offsets xml_i="10989" xml_f="11019" txt_i="5192" txt_f="5222"> was calculated using formula </offsets><sup><offsets xml_i="11024" xml_f="11025" txt_i="5222" txt_f="5223">[</offsets><xref ref-type="bibr" rid="CIT0011"><offsets xml_i="11061" xml_f="11063" txt_i="5223" txt_f="5225">11</offsets></xref><offsets xml_i="11070" xml_f="11071" txt_i="5225" txt_f="5226">]</offsets></sup><offsets xml_i="11077" xml_f="11078" txt_i="5226" txt_f="5227">.</offsets></p></sec><sec id="S20006"><title><offsets xml_i="11112" xml_f="11132" txt_i="5229" txt_f="5249">Biochemical analyses</offsets></title><p><offsets xml_i="11143" xml_f="12360" txt_i="5250" txt_f="6464">Fasted, resting morning blood samples (10 ml) were taken at the same time before and after 8 weeks intervention. For menstrual status, all the participants were menstruating regularly and defined as eumenorrheic (28- to 32-day menstrual cycles during the previous year); all testing was performed during the follicular phase of the menstrual cycle. All the subjects fasted at least for 12 hours and a fasting blood sample was obtained by venipuncture. Serum obtained was frozen at -80 °C for subsequent analysis. The serum RBP4 level was measured in duplicate using an enzyme-linked immunosorbent assay (ELISA) kits (Casabio Biotech Co. LTD.; China). The sensitivity of kit was 0.1 µg/ml. Serum glucose was determined by the enzymatic (GOD-PAP, Giucose Oxidase-Amino Antipyrine) colorimetric method (Pars Azmoun, Tehran, Iran). The intra and inter-assay coefficients of variation for glucose were &lt;1.3% and a sensitivity of 5 mg/dl. The serum insulin level was measured by an electrochemiluminescence immunoassay (ECLIA) and the insulin resistance index was calculated according to the homeostasis model assessment (HOMA-IR) which correlates well with the euglycemic hyperinsulinemic clamp in people with diabetes </offsets><sup><offsets xml_i="12365" xml_f="12366" txt_i="6464" txt_f="6465">[</offsets><xref ref-type="bibr" rid="CIT0012"><offsets xml_i="12402" xml_f="12404" txt_i="6465" txt_f="6467">12</offsets></xref><offsets xml_i="12411" xml_f="12412" txt_i="6467" txt_f="6468">]</offsets></sup><offsets xml_i="12418" xml_f="12419" txt_i="6468" txt_f="6469">.</offsets></p></sec><sec id="S20007"><title><offsets xml_i="12453" xml_f="12473" txt_i="6471" txt_f="6491">Statistical analysis</offsets></title><p><offsets xml_i="12484" xml_f="12775" txt_i="6492" txt_f="6783">Results were expressed as the mean ± SD and distributions of all variables were assessed for normality. Paired t test was used to compute mean (±SD) changes in the variables in control and training group pre- and after the intervention. A two-way ANOVA was used to determine if significant (</offsets><italic><offsets xml_i="12783" xml_f="12784" txt_i="6783" txt_f="6784">P</offsets></italic><offsets xml_i="12793" xml_f="13080" txt_i="6784" txt_f="7071">≤0.05) differences existed among the groups for biochemical variables between before and after exercise training. The relationships between variables in the training groups were determined using Spearman correlation test. The level of significance in all statistical analyses was set at </offsets><italic><offsets xml_i="13088" xml_f="13089" txt_i="7071" txt_f="7072">P</offsets></italic><offsets xml_i="13098" xml_f="13204" txt_i="7072" txt_f="7178">≤0.05. Data analyses were performed using SPSS software for windows (version 13, SPSS, Inc., Chicago, IL).</offsets></p></sec></sec><sec sec-type="results" id="S0008"><title><offsets xml_i="13262" xml_f="13269" txt_i="7181" txt_f="7188">RESULTS</offsets></title><p><offsets xml_i="13280" xml_f="13387" txt_i="7189" txt_f="7296">Physical and physiological characteristics of the subjects at baseline and after training are presented in </offsets><xref ref-type="table" rid="T0001"><offsets xml_i="13422" xml_f="13429" txt_i="7296" txt_f="7303">Table 1</offsets></xref><offsets xml_i="13436" xml_f="13794" txt_i="7303" txt_f="7658">. Before the intervention, there were no significant differences in any of variables among the two groups. Body mass and BMI increased (P &lt; 0.05) after 8 weeks aerobic exercise compared to the control group. For WHR, body fat percentage and maximal oxygen consumption there were no significant difference between the exercise group and the control group.
</offsets></p><table-wrap id="T0001" position="float"><label><offsets xml_i="13845" xml_f="13852" txt_i="7659" txt_f="7666">Table 1</offsets></label><caption><p><offsets xml_i="13872" xml_f="13970" txt_i="7666" txt_f="7764">Anthropometric and metabolic characteristics (mean ± SD) of the subjects before and after training</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" valign="middle" style="background-color: #00579e; color:white" colspan="1"><offsets xml_i="14136" xml_f="14145" txt_i="7765" txt_f="7774">Parameter</offsets></th><th align="center" colspan="2" style="background-color: #00579e; color:white" rowspan="1"><offsets xml_i="14240" xml_f="14257" txt_i="7774" txt_f="7791">Control (Mean±SD)</offsets></th><th align="center" colspan="2" style="background-color: #00579e; color:white" rowspan="1"><offsets xml_i="14352" xml_f="14370" txt_i="7791" txt_f="7809">Training (Mean±SD)</offsets></th></tr><tr><th align="center" style="background-color: #00579e; color:white" rowspan="1" colspan="1"><offsets xml_i="14474" xml_f="14486" txt_i="7809" txt_f="7821">Pre-training</offsets></th><th align="center" style="background-color: #00579e; color:white" rowspan="1" colspan="1"><offsets xml_i="14581" xml_f="14594" txt_i="7821" txt_f="7834">Post-training</offsets></th><th align="center" style="background-color: #00579e; color:white" rowspan="1" colspan="1"><offsets xml_i="14689" xml_f="14701" txt_i="7834" txt_f="7846">Pre-training</offsets></th><th align="center" style="background-color: #00579e; color:white" rowspan="1" colspan="1"><offsets xml_i="14796" xml_f="14809" txt_i="7846" txt_f="7859">Post-training</offsets></th></tr></thead><tbody><tr><td align="left" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="14913" xml_f="14914" txt_i="7859" txt_f="7860">
</offsets><bold><offsets xml_i="14920" xml_f="14934" txt_i="7860" txt_f="7874">Body mass (Kg)</offsets></bold><offsets xml_i="14941" xml_f="14942" txt_i="7874" txt_f="7875">
</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="15024" xml_f="15034" txt_i="7876" txt_f="7886">57.8 (8.4)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="15116" xml_f="15126" txt_i="7887" txt_f="7897">57.9 (8.4)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="15208" xml_f="15218" txt_i="7898" txt_f="7908">55.1 (9.1)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="15300" xml_f="15310" txt_i="7909" txt_f="7919">57.4 (9.1)</offsets><xref ref-type="table-fn" rid="TF0001"><offsets xml_i="15349" xml_f="15350" txt_i="7919" txt_f="7920">*</offsets></xref><offsets xml_i="15357" xml_f="15358" txt_i="7920" txt_f="7921">
</offsets><xref ref-type="table-fn" rid="TF0002"><offsets xml_i="15397" xml_f="15398" txt_i="7921" txt_f="7922">†</offsets></xref><offsets xml_i="15405" xml_f="15406" txt_i="7922" txt_f="7923">
</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="15461" xml_f="15462" txt_i="7924" txt_f="7925">
</offsets><bold><offsets xml_i="15468" xml_f="15489" txt_i="7925" txt_f="7946">Body mass index (Kg/m</offsets></bold><offsets xml_i="15496" xml_f="15497" txt_i="7946" txt_f="7947">
</offsets><sup><bold><offsets xml_i="15508" xml_f="15509" txt_i="7947" txt_f="7948">2</offsets></bold></sup><offsets xml_i="15522" xml_f="15523" txt_i="7948" txt_f="7949">
</offsets><bold><offsets xml_i="15529" xml_f="15530" txt_i="7949" txt_f="7950">)</offsets></bold><offsets xml_i="15537" xml_f="15538" txt_i="7950" txt_f="7951">
</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15586" xml_f="15596" txt_i="7952" txt_f="7962">21.4 (3.0)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15644" xml_f="15654" txt_i="7963" txt_f="7973">21.4 (3.0)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15702" xml_f="15712" txt_i="7974" txt_f="7984">21.3 (2.8)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15760" xml_f="15770" txt_i="7985" txt_f="7995">22.2 (2.6)</offsets><xref ref-type="table-fn" rid="TF0001"><offsets xml_i="15809" xml_f="15810" txt_i="7995" txt_f="7996">*</offsets></xref><offsets xml_i="15817" xml_f="15818" txt_i="7996" txt_f="7997">
</offsets><xref ref-type="table-fn" rid="TF0002"><offsets xml_i="15857" xml_f="15858" txt_i="7997" txt_f="7998">†</offsets></xref><offsets xml_i="15865" xml_f="15866" txt_i="7998" txt_f="7999">
</offsets></td></tr><tr><td align="left" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="15955" xml_f="15956" txt_i="8000" txt_f="8001">
</offsets><bold><offsets xml_i="15962" xml_f="15974" txt_i="8001" txt_f="8013">Body fat (%)</offsets></bold><offsets xml_i="15981" xml_f="15982" txt_i="8013" txt_f="8014">
</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="16064" xml_f="16074" txt_i="8015" txt_f="8025">17.3 (5.0)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="16156" xml_f="16166" txt_i="8026" txt_f="8036">17.8 (5.2)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="16248" xml_f="16258" txt_i="8037" txt_f="8047">18.6 (3.3)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="16340" xml_f="16350" txt_i="8048" txt_f="8058">19.0 (3.0)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="16405" xml_f="16406" txt_i="8059" txt_f="8060">
</offsets><bold><offsets xml_i="16412" xml_f="16430" txt_i="8060" txt_f="8078">Waist to hip ratio</offsets></bold><offsets xml_i="16437" xml_f="16438" txt_i="8078" txt_f="8079">
</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16486" xml_f="16497" txt_i="8080" txt_f="8091">0.74 (0.05)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16545" xml_f="16556" txt_i="8092" txt_f="8103">0.75 (0.05)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16604" xml_f="16615" txt_i="8104" txt_f="8115">0.73 (0.04)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16663" xml_f="16674" txt_i="8116" txt_f="8127">0.70 (0.03)</offsets></td></tr><tr><td align="left" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="16763" xml_f="16764" txt_i="8128" txt_f="8129">
</offsets><bold><offsets xml_i="16770" xml_f="16772" txt_i="8129" txt_f="8131">VO</offsets></bold><offsets xml_i="16779" xml_f="16780" txt_i="8131" txt_f="8132">
</offsets><sub><bold><offsets xml_i="16791" xml_f="16795" txt_i="8132" txt_f="8136">2max</offsets></bold></sub><offsets xml_i="16808" xml_f="16809" txt_i="8136" txt_f="8137">
</offsets><bold><offsets xml_i="16815" xml_f="16821" txt_i="8137" txt_f="8143">(ml.Kg</offsets></bold><offsets xml_i="16828" xml_f="16829" txt_i="8143" txt_f="8144">
</offsets><sup><bold><offsets xml_i="16840" xml_f="16842" txt_i="8144" txt_f="8146">−1</offsets></bold></sup><offsets xml_i="16855" xml_f="16856" txt_i="8146" txt_f="8147">
</offsets><bold><offsets xml_i="16862" xml_f="16866" txt_i="8147" txt_f="8151">.min</offsets></bold><offsets xml_i="16873" xml_f="16874" txt_i="8151" txt_f="8152">
</offsets><sup><bold><offsets xml_i="16885" xml_f="16887" txt_i="8152" txt_f="8154">−1</offsets></bold></sup><offsets xml_i="16900" xml_f="16901" txt_i="8154" txt_f="8155">
</offsets><bold><offsets xml_i="16907" xml_f="16908" txt_i="8155" txt_f="8156">)</offsets></bold><offsets xml_i="16915" xml_f="16916" txt_i="8156" txt_f="8157">
</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="16998" xml_f="17008" txt_i="8158" txt_f="8168">47.7 (3.5)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="17090" xml_f="17100" txt_i="8169" txt_f="8179">47.9 (3.4)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="17182" xml_f="17192" txt_i="8180" txt_f="8190">47.5 (3.8)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="17274" xml_f="17284" txt_i="8191" txt_f="8201">48.2 (2.8)</offsets></td></tr></tbody></table><table-wrap-foot><fn id="TF0001"><label><offsets xml_i="17350" xml_f="17351" txt_i="8202" txt_f="8203">*</offsets></label><p><offsets xml_i="17362" xml_f="17364" txt_i="8203" txt_f="8205">: </offsets><italic><offsets xml_i="17372" xml_f="17373" txt_i="8205" txt_f="8206">P</offsets></italic><offsets xml_i="17382" xml_f="17420" txt_i="8206" txt_f="8241">&lt;0.05 for between-group differences</offsets></p></fn><fn id="TF0002"><label><offsets xml_i="17452" xml_f="17453" txt_i="8242" txt_f="8243">†</offsets></label><p><offsets xml_i="17464" xml_f="17466" txt_i="8243" txt_f="8245">: </offsets><italic><offsets xml_i="17474" xml_f="17475" txt_i="8245" txt_f="8246">P</offsets></italic><offsets xml_i="17484" xml_f="17507" txt_i="8246" txt_f="8266">&lt;0.05, pre-training </offsets><italic><offsets xml_i="17515" xml_f="17517" txt_i="8266" txt_f="8268">vs</offsets></italic><offsets xml_i="17526" xml_f="17572" txt_i="8268" txt_f="8314">. post-training values; SD: Standard Deviation</offsets></p></fn></table-wrap-foot></table-wrap><p><offsets xml_i="17615" xml_f="17630" txt_i="8315" txt_f="8330">RBP4 (F = 0.3, </offsets><italic><offsets xml_i="17638" xml_f="17639" txt_i="8330" txt_f="8331">P</offsets></italic><offsets xml_i="17648" xml_f="17679" txt_i="8331" txt_f="8362">=0.8), fasting glucose (F = 1, </offsets><italic><offsets xml_i="17687" xml_f="17688" txt_i="8362" txt_f="8363">P</offsets></italic><offsets xml_i="17697" xml_f="17730" txt_i="8363" txt_f="8396">=0.4), fasting insulin (F = 0.4, </offsets><italic><offsets xml_i="17738" xml_f="17739" txt_i="8396" txt_f="8397">P</offsets></italic><offsets xml_i="17748" xml_f="17777" txt_i="8397" txt_f="8426">=0.8), and HOMA-IR (F = 0.7, </offsets><italic><offsets xml_i="17785" xml_f="17786" txt_i="8426" txt_f="8427">P</offsets></italic><offsets xml_i="17795" xml_f="17874" txt_i="8427" txt_f="8506">=0.5) did not change in the exercise training compared with the control group (</offsets><xref ref-type="table" rid="T0002"><offsets xml_i="17909" xml_f="17916" txt_i="8506" txt_f="8513">Table 2</offsets></xref><offsets xml_i="17923" xml_f="18075" txt_i="8513" txt_f="8665">). No significant relationships were observed between RBP4 with body mass, BMI, body fat percentage and HOMA-IR at baseline and after 8 weeks exercise.
</offsets></p><table-wrap id="T0002" position="float"><label><offsets xml_i="18126" xml_f="18133" txt_i="8666" txt_f="8673">Table 2</offsets></label><caption><p><offsets xml_i="18153" xml_f="18234" txt_i="8673" txt_f="8754">Biochemical characteristics (mean ± SD) of the subjects before and after training</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" valign="middle" style="background-color: #00579e; color:white" colspan="1"><offsets xml_i="18400" xml_f="18409" txt_i="8755" txt_f="8764">Parameter</offsets></th><th align="center" colspan="2" style="background-color: #00579e; color:white" rowspan="1"><offsets xml_i="18504" xml_f="18521" txt_i="8764" txt_f="8781">Control (mean±SD)</offsets></th><th align="center" colspan="2" style="background-color: #00579e; color:white" rowspan="1"><offsets xml_i="18616" xml_f="18634" txt_i="8781" txt_f="8799">Training (mean±SD)</offsets></th></tr><tr><th align="center" style="background-color: #00579e; color:white" rowspan="1" colspan="1"><offsets xml_i="18738" xml_f="18750" txt_i="8799" txt_f="8811">Pre-training</offsets></th><th align="center" style="background-color: #00579e; color:white" rowspan="1" colspan="1"><offsets xml_i="18845" xml_f="18858" txt_i="8811" txt_f="8824">Post-training</offsets></th><th align="center" style="background-color: #00579e; color:white" rowspan="1" colspan="1"><offsets xml_i="18953" xml_f="18965" txt_i="8824" txt_f="8836">Pre-training</offsets></th><th align="center" style="background-color: #00579e; color:white" rowspan="1" colspan="1"><offsets xml_i="19060" xml_f="19073" txt_i="8836" txt_f="8849">Post-training</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="19143" xml_f="19144" txt_i="8849" txt_f="8850">
</offsets><bold><offsets xml_i="19150" xml_f="19161" txt_i="8850" txt_f="8861">FBS (mg/dl)</offsets></bold><offsets xml_i="19168" xml_f="19169" txt_i="8861" txt_f="8862">
</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19217" xml_f="19226" txt_i="8863" txt_f="8872">90.3(8.8)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19274" xml_f="19283" txt_i="8873" txt_f="8882">85.8(8.5)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19331" xml_f="19340" txt_i="8883" txt_f="8892">89.1(2.7)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19388" xml_f="19397" txt_i="8893" txt_f="8902">84.6(7.9)</offsets></td></tr><tr><td align="left" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="19486" xml_f="19487" txt_i="8903" txt_f="8904">
</offsets><bold><offsets xml_i="19493" xml_f="19508" txt_i="8904" txt_f="8919">Insulin (µU/ml)</offsets></bold><offsets xml_i="19515" xml_f="19516" txt_i="8919" txt_f="8920">
</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="19598" xml_f="19604" txt_i="8921" txt_f="8927">8(2.9)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="19686" xml_f="19692" txt_i="8928" txt_f="8934">9.6(4)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="19774" xml_f="19783" txt_i="8935" txt_f="8944">10.2(4.1)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="19865" xml_f="19874" txt_i="8945" txt_f="8954">10.1(2.3)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="19929" xml_f="19930" txt_i="8955" txt_f="8956">
</offsets><bold><offsets xml_i="19936" xml_f="19943" txt_i="8956" txt_f="8963">HOMA-IR</offsets></bold><offsets xml_i="19950" xml_f="19951" txt_i="8963" txt_f="8964">
</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19999" xml_f="20007" txt_i="8965" txt_f="8973">1.7(0.5)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="20055" xml_f="20063" txt_i="8974" txt_f="8982">1.9(0.7)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="20111" xml_f="20119" txt_i="8983" txt_f="8991">2.2(0.9)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="20167" xml_f="20173" txt_i="8992" txt_f="8998">2(0.5)</offsets></td></tr><tr><td align="left" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="20262" xml_f="20263" txt_i="8999" txt_f="9000">
</offsets><bold><offsets xml_i="20269" xml_f="20281" txt_i="9000" txt_f="9012">RBP4 (µg/ml)</offsets></bold><offsets xml_i="20288" xml_f="20289" txt_i="9012" txt_f="9013">
</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="20371" xml_f="20380" txt_i="9014" txt_f="9023">11.6(4.1)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="20462" xml_f="20471" txt_i="9024" txt_f="9033">12.5(3.3)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="20553" xml_f="20562" txt_i="9034" txt_f="9043">12.5(3.4)</offsets></td><td align="center" style="background-color: #d0d0fd" rowspan="1" colspan="1"><offsets xml_i="20644" xml_f="20653" txt_i="9044" txt_f="9053">12.9(3.9)</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="20703" xml_f="20825" txt_i="9054" txt_f="9176">SD: Standard Deviation; FBS: Fasting blood glucose; HOMA-IR: homeostasis model assessment; RBP4: Retinol binding protein 4</offsets></p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="S0009"><title><offsets xml_i="20916" xml_f="20926" txt_i="9178" txt_f="9188">DISCUSSION</offsets></title><p><offsets xml_i="20937" xml_f="21061" txt_i="9189" txt_f="9313">RBP4, has recently been identified as a novel adipokine associated with obesity, type 2 diabetes and the metabolic syndrome </offsets><sup><offsets xml_i="21066" xml_f="21067" txt_i="9313" txt_f="9314">[</offsets><xref ref-type="bibr" rid="CIT0001"><offsets xml_i="21103" xml_f="21104" txt_i="9314" txt_f="9315">1</offsets></xref><offsets xml_i="21111" xml_f="21113" txt_i="9315" txt_f="9317">, </offsets><xref ref-type="bibr" rid="CIT0002"><offsets xml_i="21149" xml_f="21150" txt_i="9317" txt_f="9318">2</offsets></xref><offsets xml_i="21157" xml_f="21159" txt_i="9318" txt_f="9320">, </offsets><xref ref-type="bibr" rid="CIT0013"><offsets xml_i="21195" xml_f="21197" txt_i="9320" txt_f="9322">13</offsets></xref><offsets xml_i="21204" xml_f="21205" txt_i="9322" txt_f="9323">]</offsets></sup><offsets xml_i="21211" xml_f="21607" txt_i="9323" txt_f="9719">. The effects of exercise training on serum RBP4 is still unclear. The purpose of this study was to examine the effects of 8 weeks moderate aerobic exercise on serum RBP4 levels in female athletes. Our results showed that RBP4 levels at baseline were lower in female athletes (median 11.6 [range 3.7–16.7 µg/ml]) than in impaired glucose tolerance, type 2 diabetic and healthy subjects. Cho et al</offsets><sup><offsets xml_i="21612" xml_f="21613" txt_i="9719" txt_f="9720">[</offsets><xref ref-type="bibr" rid="CIT0014"><offsets xml_i="21649" xml_f="21651" txt_i="9720" txt_f="9722">14</offsets></xref><offsets xml_i="21658" xml_f="21659" txt_i="9722" txt_f="9723">]</offsets></sup><offsets xml_i="21665" xml_f="21983" txt_i="9723" txt_f="10041"> demonstrated median levels of plasma RBP4 concentrations in the impaired glucose tolerance (median 18.9 [range 11.2–45.8 µg/ml]), type 2 diabetic patients (median 20.9 [range 9.9–48.5 µg/ml]) and healthy subjects (median 18.1 [9.3–30.5 µg/ml]). Thus it seems that practicing karate improves levels of RBP4 in females.</offsets></p><p><offsets xml_i="21990" xml_f="22195" txt_i="10042" txt_f="10247">Our results are in agreement with previous reports showing that there was no relationship between RBP4 levels and body composition parameters including body mass, BMI and WHR in female athletes. Cho et al </offsets><sup><offsets xml_i="22200" xml_f="22201" txt_i="10247" txt_f="10248">[</offsets><xref ref-type="bibr" rid="CIT0006"><offsets xml_i="22237" xml_f="22238" txt_i="10248" txt_f="10249">6</offsets></xref><offsets xml_i="22245" xml_f="22246" txt_i="10249" txt_f="10250">]</offsets></sup><offsets xml_i="22252" xml_f="22353" txt_i="10250" txt_f="10351"> indicated that RBP4 levels were not associated with body mass in obese Korean women. Mansouri et al </offsets><sup><offsets xml_i="22358" xml_f="22359" txt_i="10351" txt_f="10352">[</offsets><xref ref-type="bibr" rid="CIT0007"><offsets xml_i="22395" xml_f="22396" txt_i="10352" txt_f="10353">7</offsets></xref><offsets xml_i="22403" xml_f="22404" txt_i="10353" txt_f="10354">]</offsets></sup><offsets xml_i="22410" xml_f="23027" txt_i="10354" txt_f="10971"> also demonstrated that RBP4 levels were not associated with BMI in young male students. However, this could be attributed to differences in subject populations because our subjects were athletes while non-athlete middle-aged women were participated in the Lim et al study. The results showed that body fat percentage did not significantly change after 8 weeks exercise, thus it seems that the lack of effect of exercise training on RBP4 in the present study might be due to the absence of reductions in body fat percentage. Studies demonstrated that the response of RBP4 to 1 month of exercise training was variable </offsets><sup><offsets xml_i="23032" xml_f="23033" txt_i="10971" txt_f="10972">[</offsets><xref ref-type="bibr" rid="CIT0002"><offsets xml_i="23069" xml_f="23070" txt_i="10972" txt_f="10973">2</offsets></xref><offsets xml_i="23077" xml_f="23078" txt_i="10973" txt_f="10974">]</offsets></sup><offsets xml_i="23084" xml_f="23193" txt_i="10974" txt_f="11083">, and RBP4 levels were decreased after exercise mainly in the subjects having higher RBP4 levels at baseline </offsets><sup><offsets xml_i="23198" xml_f="23199" txt_i="11083" txt_f="11084">[</offsets><xref ref-type="bibr" rid="CIT0008"><offsets xml_i="23235" xml_f="23236" txt_i="11084" txt_f="11085">8</offsets></xref><offsets xml_i="23243" xml_f="23244" txt_i="11085" txt_f="11086">]</offsets></sup><offsets xml_i="23250" xml_f="23376" txt_i="11086" txt_f="11212">. Research results showed that the basic level of RBP4 appeared to be the only predictor of after exercise RBP4 concentration </offsets><sup><offsets xml_i="23381" xml_f="23382" txt_i="11212" txt_f="11213">[</offsets><xref ref-type="bibr" rid="CIT0007"><offsets xml_i="23418" xml_f="23419" txt_i="11213" txt_f="11214">7</offsets></xref><offsets xml_i="23426" xml_f="23427" txt_i="11214" txt_f="11215">]</offsets></sup><offsets xml_i="23433" xml_f="23635" txt_i="11215" txt_f="11417">. Our results demonstrated that RBP4 levels at baseline were lower than the subjects that participated in the Lim et al study, suggesting that athletes might have lower levels of RPB4 than non-athletes.</offsets></p><p><offsets xml_i="23642" xml_f="23757" txt_i="11418" txt_f="11533">On the other hand, elevated RBP4 levels have been reported in subjects with insulin resistance and type 2 diabetes </offsets><sup><offsets xml_i="23762" xml_f="23763" txt_i="11533" txt_f="11534">[</offsets><xref ref-type="bibr" rid="CIT0002"><offsets xml_i="23799" xml_f="23800" txt_i="11534" txt_f="11535">2</offsets></xref><offsets xml_i="23807" xml_f="23809" txt_i="11535" txt_f="11537">, </offsets><xref ref-type="bibr" rid="CIT0006"><offsets xml_i="23845" xml_f="23846" txt_i="11537" txt_f="11538">6</offsets></xref><offsets xml_i="23853" xml_f="23854" txt_i="11538" txt_f="11539">]</offsets></sup><offsets xml_i="23860" xml_f="23963" txt_i="11539" txt_f="11642"> whereas other studies showed no relationship between circulating RBP4, obesity and insulin resistance </offsets><sup><offsets xml_i="23968" xml_f="23969" txt_i="11642" txt_f="11643">[</offsets><xref ref-type="bibr" rid="CIT0007"><offsets xml_i="24005" xml_f="24006" txt_i="11643" txt_f="11644">7</offsets></xref><offsets xml_i="24013" xml_f="24015" txt_i="11644" txt_f="11646">, </offsets><xref ref-type="bibr" rid="CIT0015"><offsets xml_i="24051" xml_f="24053" txt_i="11646" txt_f="11648">15</offsets></xref><offsets xml_i="24060" xml_f="24062" txt_i="11648" txt_f="11650">, </offsets><xref ref-type="bibr" rid="CIT0016"><offsets xml_i="24098" xml_f="24100" txt_i="11650" txt_f="11652">16</offsets></xref><offsets xml_i="24107" xml_f="24108" txt_i="11652" txt_f="11653">]</offsets></sup><offsets xml_i="24114" xml_f="24254" txt_i="11653" txt_f="11793">. Our results showed that there was no significant relationship between RBP4 levels and insulin resistance determined by HOMA-IR. Cho et al </offsets><sup><offsets xml_i="24259" xml_f="24260" txt_i="11793" txt_f="11794">[</offsets><xref ref-type="bibr" rid="CIT0006"><offsets xml_i="24296" xml_f="24297" txt_i="11794" txt_f="11795">6</offsets></xref><offsets xml_i="24304" xml_f="24305" txt_i="11795" txt_f="11796">]</offsets></sup><offsets xml_i="24311" xml_f="24331" txt_i="11796" txt_f="11816"> and Mansouri et al </offsets><sup><offsets xml_i="24336" xml_f="24337" txt_i="11816" txt_f="11817">[</offsets><xref ref-type="bibr" rid="CIT0007"><offsets xml_i="24373" xml_f="24374" txt_i="11817" txt_f="11818">7</offsets></xref><offsets xml_i="24381" xml_f="24382" txt_i="11818" txt_f="11819">]</offsets></sup><offsets xml_i="24388" xml_f="24482" txt_i="11819" txt_f="11913"> also indicated that RBP4 levels were not associated with insulin resistance while, Lim et al </offsets><sup><offsets xml_i="24487" xml_f="24488" txt_i="11913" txt_f="11914">[</offsets><xref ref-type="bibr" rid="CIT0008"><offsets xml_i="24524" xml_f="24525" txt_i="11914" txt_f="11915">8</offsets></xref><offsets xml_i="24532" xml_f="24533" txt_i="11915" txt_f="11916">]</offsets></sup><offsets xml_i="24539" xml_f="24758" txt_i="11916" txt_f="12135"> showed that there was a positive relationship between RBP4 concentration and insulin resistance. In our study, there was virtually no change in fasting glucose and insulin and HOMA-IR after 8 weeks training. Lim et al </offsets><sup><offsets xml_i="24763" xml_f="24764" txt_i="12135" txt_f="12136">[</offsets><xref ref-type="bibr" rid="CIT0008"><offsets xml_i="24800" xml_f="24801" txt_i="12136" txt_f="12137">8</offsets></xref><offsets xml_i="24808" xml_f="24809" txt_i="12137" txt_f="12138">]</offsets></sup><offsets xml_i="24815" xml_f="25169" txt_i="12138" txt_f="12492"> however, reported that insulin resistance decreased after 10 weeks exercise training in young and middle-aged women. We had some limitations in this study. We did not measure inflammatory markers and cardiovascular risk factors. Previous studies demonstrated that RBP4 concentrations were associated with inflammatory markers such as C-reactive protein </offsets><sup><offsets xml_i="25174" xml_f="25175" txt_i="12492" txt_f="12493">[</offsets><xref ref-type="bibr" rid="CIT0017"><offsets xml_i="25211" xml_f="25213" txt_i="12493" txt_f="12495">17</offsets></xref><offsets xml_i="25220" xml_f="25221" txt_i="12495" txt_f="12496">]</offsets></sup><offsets xml_i="25227" xml_f="25281" txt_i="12496" txt_f="12550"> and cardiovascular risk factors such as triglyceride </offsets><sup><offsets xml_i="25286" xml_f="25287" txt_i="12550" txt_f="12551">[</offsets><xref ref-type="bibr" rid="CIT0009"><offsets xml_i="25323" xml_f="25324" txt_i="12551" txt_f="12552">9</offsets></xref><offsets xml_i="25331" xml_f="25332" txt_i="12552" txt_f="12553">]</offsets></sup><offsets xml_i="25338" xml_f="25358" txt_i="12553" txt_f="12573">, total cholesterol </offsets><sup><offsets xml_i="25363" xml_f="25364" txt_i="12573" txt_f="12574">[</offsets><xref ref-type="bibr" rid="CIT0006"><offsets xml_i="25400" xml_f="25401" txt_i="12574" txt_f="12575">6</offsets></xref><offsets xml_i="25408" xml_f="25409" txt_i="12575" txt_f="12576">]</offsets></sup><offsets xml_i="25415" xml_f="25462" txt_i="12576" txt_f="12623"> and low density lipoprotein (LDL) cholesterol </offsets><sup><offsets xml_i="25467" xml_f="25468" txt_i="12623" txt_f="12624">[</offsets><xref ref-type="bibr" rid="CIT0006"><offsets xml_i="25504" xml_f="25505" txt_i="12624" txt_f="12625">6</offsets></xref><offsets xml_i="25512" xml_f="25513" txt_i="12625" txt_f="12626">]</offsets></sup><offsets xml_i="25519" xml_f="25678" txt_i="12626" txt_f="12785">. If we could measure these markers, we could carefully explain the changes of RBP4 concentrations in response to 8 weeks exercise training in female athletes.</offsets></p></sec><sec sec-type="conclusion" id="S0010"><title><offsets xml_i="25733" xml_f="25743" txt_i="12787" txt_f="12797">CONCLUSION</offsets></title><p><offsets xml_i="25754" xml_f="26116" txt_i="12798" txt_f="13160">RBP4 level associated with obesity profiles and insulin resistance, thus we examined if exercise training would reduce the body fat and insulin resistance and decrease RBP4 concentrations. Our results showed that serum RBP4 levels were not affected by 8 weeks moderate aerobic exercise in female athletes. Additional research is needed to examine our hypothesis.</offsets></p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>The work was supported by grants from the Fars Science &amp; Research branch, Islamic Azad University. The authors gratefully acknowledge the all subjects whom cooperated in this investigation.</p></ack><sec><title></title><p>
<bold>Conflict of interests:</bold> None</p></sec><ref-list><title>REFERENCES</title><ref id="CIT0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Graham</surname><given-names>TE</given-names></name><name><surname>Mody</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes</article-title><source>Nature</source><year>2005</year><volume>436</volume><fpage>356</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">16034410</pub-id></element-citation></ref><ref id="CIT0002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>TE</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects</article-title><source>New Engl J Med</source><year>2006</year><volume>354</volume><fpage>2552</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">16775236</pub-id></element-citation></ref><ref id="CIT0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quadro</surname><given-names>L</given-names></name><name><surname>Blaner</surname><given-names>WS</given-names></name><name><surname>Salchow</surname><given-names>DJ</given-names></name><etal></etal></person-group><article-title>Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein</article-title><source>EMBO J</source><year>1999</year><volume>18</volume><fpage>4633</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">10469643</pub-id></element-citation></ref><ref id="CIT0004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klöting</surname><given-names>N</given-names></name><name><surname>Graham</surname><given-names>TE</given-names></name><name><surname>Berndt</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass</article-title><source>Cell Metab</source><year>2007</year><volume>6</volume><fpage>79</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">17618858</pub-id></element-citation></ref><ref id="CIT0005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>JA</given-names></name><name><surname>Kim</surname><given-names>NH</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><etal></etal></person-group><article-title>Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease</article-title><source>Clin Endocrinol</source><year>2008</year><volume>68</volume><fpage>555</fpage><lpage>60</lpage></element-citation></ref><ref id="CIT0006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>YM</given-names></name><name><surname>Youn</surname><given-names>BS</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><fpage>2457</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17065684</pub-id></element-citation></ref><ref id="CIT0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansouri</surname><given-names>M</given-names></name><name><surname>Keshtkar</surname><given-names>A</given-names></name><name><surname>Hasani-Ranjbar</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>The impact of one session resistance exercise on plasma adiponectin and RBP4 concentration in trained and untrained healthy young men</article-title><source>Endocr J</source><year>2011</year><volume>58</volume><fpage>861</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21836369</pub-id></element-citation></ref><ref id="CIT0008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Jeong</surname><given-names>IK</given-names></name><etal></etal></person-group><article-title>Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women</article-title><source>J Clin Endocrinol Metab</source><year>2008</year><volume>93</volume><fpage>2263</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18334592</pub-id></element-citation></ref><ref id="CIT0009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Numao</surname><given-names>S</given-names></name><name><surname>Sasai</surname><given-names>H</given-names></name><name><surname>Nomata</surname><given-names>Y</given-names></name><etal></etal></person-group><article-title>Effects of exercise training on circulating retinol-binding protein 4 and cardiovascular disease risk factors in obese men</article-title><source>Obes Facts</source><year>2012</year><volume>5</volume><fpage>845</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">23258073</pub-id></element-citation></ref><ref id="CIT0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>YH</given-names></name><name><surname>Han</surname><given-names>KA</given-names></name><name><surname>Ahn</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Resistance exercise did not alter intramuscular adipose tissue but reduced retinol-binding protein-4 concentration in individuals with type 2 diabetes mellitus</article-title><source>J Int Med Res</source><year>2010</year><volume>38</volume><fpage>782</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">20819415</pub-id></element-citation></ref><ref id="CIT0011"><label>11</label><element-citation publication-type="book"><article-title>ACSM</article-title><source>ACSM guidelines for exercise testing and prescription</source><year>2005</year><edition>7th ed</edition><publisher-loc>Philadelphia: Lippincott</publisher-loc><publisher-name>Williams and Wilkins</publisher-name><fpage>21</fpage><lpage>30</lpage></element-citation></ref><ref id="CIT0012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Hosker</surname><given-names>JP</given-names></name><name><surname>Rudenski</surname><given-names>AS</given-names></name><etal></etal></person-group><article-title>Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man</article-title><source>Diabetologia</source><year>1985</year><volume>28</volume><fpage>412</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3899825</pub-id></element-citation></ref><ref id="CIT0013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavi</surname><given-names>S</given-names></name><name><surname>Stuart</surname><given-names>LM</given-names></name><name><surname>Kelly</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><fpage>1886</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">17299074</pub-id></element-citation></ref><ref id="CIT0014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>YM</given-names></name><name><surname>Youn</surname><given-names>BS</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><fpage>2457</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17065684</pub-id></element-citation></ref><ref id="CIT0015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janke</surname><given-names>J</given-names></name><name><surname>Engli</surname><given-names>S</given-names></name><name><surname>Boschmann</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Retinol-binding protein 4 in human obesity</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2805</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">17003346</pub-id></element-citation></ref><ref id="CIT0016"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao-Borengasser</surname><given-names>A</given-names></name><name><surname>Varma</surname><given-names>V</given-names></name><name><surname>Bodles</surname><given-names>AM</given-names></name><etal></etal></person-group><article-title>Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><fpage>2590</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17595259</pub-id></element-citation></ref><ref id="CIT0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><etal></etal></person-group><article-title>Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><fpage>4827</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">17878249</pub-id></element-citation></ref></ref-list></back></article>